Survival analysis for GREM1, BAG2, TRIP6, OLFM4 and MAGE-A9 mRNA expression from the TCGA dataset from patients with the diffuse or intestinal subtypes of gastric cancer did not show any statistically significant difference. This evidence concerns the gene TRIP6 and gastric cancer.